I would imagine MYNZ's ColoAlert is a shoo-in for US approval. I'd forgotten about the lab processing issue, but I'm holding my fire on that despite the clear logic of yours. Time will tell if QC really suffers. My main (pun not actually intended) concern about MYNZ is another observation of yours about the more generalized difficulty for medical device companies in turning a profit. Consequently, I'm still watchfully on the sidelines in this space.
I never heard this before but just today, my Doc told me I wasn't permitted to get a cologuard type test because the the type of polyps I've had in the past. The test would automatically come back with a false positive.
Market Data 
Markets 
AI
